Ureteral Stents Market Size, Share & Industry Analysis, By Type (Open Ended, Closed Ended, Double Pigtail, Others), By Applications (Kidney Stones, Kidney Transplant, Urinary Incontinence, Others), By Material (Metal Stents, Polyurethane, Silicon, Hydrogel, Others), By End User (Hospitals, Research and academic centres, Speciality clinics, Others) and Regional Forecast, 2026-2034

The global ureteral stents market size was valued at USD 0.63 billion in 2025. The market is projected to grow from USD 0.67 billion in 2026 to USD 1.15 billion by 2034, exhibiting a CAGR of 6.99% during the forecast period.

The Ureteral Stents Market forms a critical segment of the urology medical devices industry, supporting urinary drainage and obstruction management across a wide range of clinical conditions. Ureteral stents are widely used in procedures involving kidney stones, ureteral strictures, post-surgical recovery, and transplant care. Growing adoption of minimally invasive urological procedures has significantly increased demand for advanced stent designs. Continuous innovation in materials, coatings, and flexibility has improved patient comfort and procedural efficiency. Healthcare providers increasingly prefer stents that reduce complications such as encrustation and infection. Rising awareness of early urological intervention supports market expansion. The Ureteral Stents Market Outlook remains positive due to procedural volume growth and technology-driven advancements.

The United States Ureteral Stents Market represents a major share of global demand due to high procedural volumes and advanced healthcare infrastructure. Strong adoption of minimally invasive urological surgeries drives consistent utilization of ureteral stents across hospitals and specialty clinics. The presence of skilled urologists and advanced diagnostic capabilities supports early intervention. Product innovation focusing on patient comfort and reduced complications is well received. Reimbursement support and established regulatory pathways facilitate commercialization. Increasing prevalence of kidney stones and chronic urological conditions further strengthens demand. The U.S. market emphasizes quality, safety, and clinical performance, making it a key contributor to overall Ureteral Stents Market Growth.

Key Findings

Market Size & Growth

• Global Market Size 2025: USD 0.63 billion
• Global Market Forecast 2034: USD 1.15 billion
• CAGR (2025–2034): 6.99%

Market Share – Regional

• North America: 38%
• Europe: 27%
• Asia-Pacific: 25%
• Rest of the World: 10%

Country - Level Shares

• Germany: 9% of Europe’s market 
• United Kingdom: 8% of Europe’s market 
• Japan: 7% of Asia-Pacific market 
• China: 10% of Asia-Pacific market 

Ureteral Stents Market Latest Trends

The Ureteral Stents Market is witnessing several transformative trends driven by clinical needs and technological innovation. One of the most prominent Ureteral Stents Market Trends is the growing preference for minimally invasive urological procedures, which increases reliance on advanced stent solutions. Manufacturers are focusing on stent designs that improve flexibility, reduce irritation, and minimize patient discomfort during long-term placement. Antimicrobial and drug-coated stents are gaining traction as they help reduce infection risk and encrustation.

Another key trend in Ureteral Stents Market Analysis is the shift toward customized stent sizing and patient-specific designs. Improved imaging technologies enable more precise stent placement. Material innovation, particularly in polymers and silicone-based products, enhances biocompatibility and durability. Single-use sterile stents are increasingly preferred to reduce infection risks. Hospitals are also adopting stents with improved visibility for easier insertion. These trends collectively support innovation, improve clinical outcomes, and strengthen the Ureteral Stents Market Outlook.

Download Free sample to learn more about this report.

Ureteral Stents Market Dynamics

DRIVER

Rising prevalence of urological disorders and minimally invasive procedures

The primary driver of Ureteral Stents Market Growth is the increasing prevalence of urological disorders such as kidney stones, ureteral obstructions, and post-surgical complications. Sedentary lifestyles, dietary habits, and aging populations contribute to rising incidence rates. Minimally invasive procedures such as ureteroscopy and endoscopic stone removal require ureteral stent placement for drainage and healing. Healthcare providers favor stents due to procedural efficiency and reduced hospital stays. Technological advancements improve safety and ease of use. Increased awareness among patients supports early diagnosis. Expanding healthcare access further boosts procedural volumes. These factors collectively drive sustained demand within the Ureteral Stents Industry Analysis.

RESTRAINT

Risk of complications and patient discomfort

Despite clinical benefits, complications associated with ureteral stents act as a restraint on market growth. Patients may experience discomfort, urinary symptoms, encrustation, and infection during prolonged stent use. Removal procedures can cause anxiety and pain. Lack of patient compliance in follow-up visits increases risks. Some clinicians prefer alternative treatment approaches in mild cases. Cost concerns related to advanced stent technologies can limit adoption in resource-constrained settings. These challenges impact patient satisfaction and treatment outcomes. Addressing these issues remains essential for long-term Ureteral Stents Market Opportunities.

OPPORTUNITY

Innovation in stent materials and coatings

Innovation in materials and coatings presents a significant opportunity within the Ureteral Stents Market. Manufacturers are investing in antimicrobial, hydrophilic, and biodegradable coatings to reduce infection and encrustation risks. Development of metal and hybrid stents supports long-term use cases. Drug-eluting stents offer targeted therapeutic benefits. Personalized stent solutions enhance patient comfort and outcomes. Emerging markets present untapped opportunities due to expanding healthcare infrastructure. Collaboration between medical device companies and research institutions accelerates innovation. These developments enhance the Ureteral Stents Market Outlook and expand clinical applications.

CHALLENGE

Regulatory complexity and clinical adoption barriers

Regulatory requirements for medical devices present ongoing challenges in the Ureteral Stents Market. Approval processes can be time-consuming and costly. Clinical validation requirements vary across regions. Training clinicians on new stent designs requires investment. Resistance to adopting new technologies can slow market penetration. Ensuring consistent product quality across global supply chains remains challenging. These factors influence commercialization timelines and competitive dynamics. Overcoming these challenges is essential for sustained Ureteral Stents Market Growth.

Ureteral Stents Market Segmentation

By Type

Open ended ureteral stents account for approximately 30% of the Ureteral Stents Market share due to their simplicity and ease of placement. These stents are widely used for short-term urinary drainage in uncomplicated clinical cases. Their straight, open-ended design allows smooth insertion and quick removal, reducing procedural complexity. Hospitals prefer these stents for routine urological interventions where temporary drainage is sufficient. Cost-effectiveness plays a key role in adoption, especially in high-volume healthcare settings. Open ended stents reduce procedure time and improve workflow efficiency. Clinicians value their predictable performance. However, limited long-term stability restricts extended use. Despite this, demand remains steady. This segment contributes consistently to overall Ureteral Stents Market Size.

Closed ended ureteral stents hold approximately 20% of the Ureteral Stents Market share and are designed to minimize stent migration. These stents are commonly used in controlled drainage applications where stability is critical. The closed-tip design enhances positioning accuracy and reduces displacement risks. They are frequently used in post-operative recovery following urological surgeries. Material durability allows longer indwelling periods compared to open ended variants. Hospitals utilize these stents in complex cases requiring reliable drainage control. Improved procedural outcomes support adoption. Growing awareness among clinicians boosts demand. Their use is expanding in specialized urology practices. This segment supports procedural safety and clinical precision.

Double pigtail stents dominate the Ureteral Stents Market with approximately 35% market share. Their coiled ends at both extremities prevent migration and ensure secure placement within the urinary tract. These stents are widely used in kidney stone management and ureteral obstruction treatment. High patient tolerance supports both short-term and long-term use. Double pigtail designs are compatible with minimally invasive procedures, driving widespread adoption. Manufacturers prioritize innovation in this segment due to high demand. Advanced coatings improve comfort and reduce complications. Hospitals prefer these stents for reliability. Strong clinical acceptance sustains growth. This segment leads overall Ureteral Stents Market Share.

Other ureteral stent types account for approximately 15% of the Ureteral Stents Market share and include specialty and customized designs. These stents are developed for unique anatomical or clinical requirements. They are often used in complex urological conditions and rare procedural cases. Innovation plays a critical role in this segment’s growth. Customized sizing and specialized materials improve patient outcomes. Adoption is increasing in advanced healthcare centers. These stents address unmet clinical needs. Higher costs limit mass adoption. However, demand continues to rise in niche applications. This segment enhances overall market diversity.

By Application

Kidney stone treatment represents approximately 40% of the Ureteral Stents Market share, making it the largest application segment. Rising incidence of kidney stones globally drives consistent demand. Ureteral stents support drainage and healing after stone removal procedures. Minimally invasive techniques such as ureteroscopy rely heavily on stent placement. Hospitals and specialty clinics perform high volumes of these procedures. Early intervention increases stent utilization. Improved diagnostic capabilities support procedural growth. Patient awareness further boosts demand. Technological advancements enhance treatment outcomes. This application remains central to Ureteral Stents Market Growth.

Kidney transplant applications account for approximately 20% of the Ureteral Stents Market share. Stents are used to support ureteral anastomosis healing after transplant surgery. They help prevent leakage, obstruction, and post-operative complications. Specialized stent designs improve graft survival rates. Transplant centers rely on high-quality stents for procedural success. Long-term reliability is critical in this application. Adoption is supported by rising transplant procedures globally. Advanced healthcare infrastructure supports usage. Continuous innovation improves outcomes. This segment plays a vital role in clinical success.

Urinary incontinence applications hold around 15% of the Ureteral Stents Market share. Stents assist in managing urinary flow and structural abnormalities. Adoption is driven by aging populations and rising urological disorders. These stents are used as supportive tools in select treatment pathways. Growing awareness improves diagnosis rates. Specialty clinics play a key role in utilization. Patient comfort remains a priority in product selection. Technological improvements enhance usability. Adoption is gradual but consistent. This segment contributes steadily to market expansion.

Other applications account for approximately 25% of the Ureteral Stents Market share. These include trauma-related procedures, congenital abnormalities, and post-surgical complications. Demand is driven by diverse clinical requirements. Hospitals use stents in emergency and complex cases. Custom solutions address patient-specific needs. This segment benefits from innovation in materials and design. Adoption varies by healthcare infrastructure. Advanced centers contribute higher usage. Clinical flexibility supports demand. This segment adds resilience to overall market performance.

By Material

Metal ureteral stents represent approximately 20% of the Ureteral Stents Market share. These stents are designed for long-term use in chronic conditions. High durability and structural strength support extended indwelling periods. Metal stents reduce the need for frequent replacements. They are commonly used in malignant obstructions. Advanced engineering improves flexibility and comfort. Higher costs limit widespread adoption. However, clinical benefits justify use in complex cases. Demand is increasing in specialized settings. This segment supports long-term treatment strategies.

Polyurethane stents hold around 25% market share due to their flexibility and cost efficiency. These stents offer a balance between durability and patient comfort. Hospitals favor polyurethane for routine procedures. Ease of manufacturing supports availability. Material adaptability enables various stent designs. Polyurethane stents are widely used in short-to-medium term placements. Adoption is high in emerging markets. Cost advantages support volume sales. Continuous improvements enhance biocompatibility. This segment remains commercially significant.

Silicone ureteral stents dominate the market with approximately 30% share. High biocompatibility reduces irritation and discomfort. These stents are preferred for long-term placements. Silicone materials minimize encrustation risks. Patient tolerance supports higher satisfaction levels. Hospitals widely adopt silicone stents in complex cases. Advanced designs improve flow dynamics. Manufacturing innovation enhances consistency. Adoption remains strong across regions. This segment leads material-based Ureteral Stents Market Share.

Hydrogel stents account for approximately 15% of the Ureteral Stents Market share. These stents feature lubricious coatings that reduce friction. Improved comfort enhances patient compliance. Hydrogel materials minimize irritation during insertion and removal. Adoption is increasing in advanced healthcare facilities. These stents reduce complication risks. Technological innovation supports wider use. Cost remains a consideration. Clinical acceptance continues to grow. This segment shows strong future potential.

Other materials contribute around 10% of the Ureteral Stents Market share. This category includes hybrid polymers and experimental materials. These stents are used in specialized applications. Innovation drives material development. Clinical trials support validation. Adoption is limited but expanding. Custom solutions address specific needs. Higher costs restrict volume. Research investments fuel growth. This segment supports future innovation.

By End User

Hospitals dominate the Ureteral Stents Market with approximately 45% share. High surgical volumes drive consistent demand. Advanced infrastructure supports adoption. Hospitals perform complex and routine procedures. Access to skilled urologists increases usage. Procurement contracts support volume purchasing. Technological integration improves outcomes. Hospitals prioritize quality and safety. This segment anchors overall market demand. Growth remains stable.

Research and academic centers account for approximately 15% of market share. These institutions support innovation and clinical trials. New stent designs are tested in these settings. Collaboration with manufacturers drives development. Adoption focuses on advanced technologies. Procedure volumes are moderate. Educational programs increase clinician expertise. Funding supports experimentation. This segment influences future market trends. It plays a strategic role in innovation.

Specialty clinics hold around 25% of the Ureteral Stents Market share. These clinics focus on minimally invasive urology procedures. High patient turnover supports demand. Clinics prefer efficient and reliable stents. Cost considerations influence procurement. Technological advancements support outpatient care. Patient convenience drives adoption. Growth is strong in urban areas. Specialty expertise enhances outcomes. This segment continues expanding.

Other end users represent approximately 15% of market share and include ambulatory and outpatient centers. These facilities support minor and follow-up procedures. Cost-effective stents are preferred. Growing outpatient care trends support demand. Accessibility improves patient reach. Limited infrastructure restricts complex cases. Adoption varies regionally. Innovation improves suitability. This segment adds flexibility to the market.

Ureteral Stents Market Regional Outlook

North America

North America holds approximately 38% of the Ureteral Stents Market share, making it the leading regional market globally. The presence of advanced healthcare infrastructure supports a high volume of urological procedures. Strong adoption of minimally invasive surgical techniques drives consistent demand for ureteral stents. Favorable reimbursement frameworks encourage hospitals to adopt advanced stent technologies. High awareness among patients leads to early diagnosis and treatment of urological conditions. Continuous product innovation is rapidly accepted by clinicians. The region benefits from skilled urologists and specialized healthcare centers. Regulatory clarity supports faster commercialization of new devices. Strong clinical outcomes reinforce trust in stent usage. North America remains a core contributor to overall Ureteral Stents Market Growth.

Europe

Europe accounts for approximately 27% of the global Ureteral Stents Market share and represents a mature yet steadily expanding region. Well-established public healthcare systems support consistent procedure volumes across countries. Strict regulatory standards ensure high-quality product adoption. Aging populations across Europe significantly increase the prevalence of urological disorders. Hospitals prioritize patient safety and long-term clinical outcomes. Technological innovation is selectively adopted based on cost-effectiveness. Collaboration between healthcare providers and manufacturers supports innovation. Training programs enhance clinician expertise. Demand remains stable across both Western and Eastern Europe. The region contributes substantially to global Ureteral Stents Market Insights.

Germany Ureteral Stents Market

Germany represents approximately 9% of the global Ureteral Stents Market share and is a key contributor within Europe. The country emphasizes precision medicine and high clinical standards. Advanced hospital infrastructure supports the use of premium ureteral stents. Strong regulatory compliance influences product selection and procurement decisions. Germany has a high volume of specialized urology centers. Aging demographics drive demand for urological interventions. Innovation adoption focuses on patient safety and durability. Clinician preference for high-quality materials boosts silicone and advanced stents. Research institutions support clinical validation. Germany remains a stable and technology-driven market.

United Kingdom Ureteral Stents Market

The United Kingdom accounts for approximately 8% of the global Ureteral Stents Market share. A centralized healthcare system supports standardized treatment protocols. Hospitals rely on proven stent technologies with strong clinical performance. Demand is driven by a rising elderly population and urological disease prevalence. Cost-efficiency plays a key role in procurement decisions. Minimally invasive procedures are widely practiced. Innovation adoption focuses on improving patient comfort. Training initiatives enhance procedural outcomes. Specialty clinics contribute to increasing stent usage. The UK remains a consistent contributor to European market stability.

Asia-Pacific

Asia-Pacific holds approximately 25% of the Ureteral Stents Market share and is the fastest-expanding regional segment. Growing healthcare access significantly increases procedure volumes. Rising awareness of urological health supports early diagnosis. Government investments improve hospital infrastructure. Expanding medical tourism boosts demand in select countries. Local manufacturing improves product affordability. Adoption of minimally invasive techniques continues to rise. Urbanization drives healthcare modernization. Multinational manufacturers expand regional presence. Asia-Pacific offers strong long-term Ureteral Stents Market Opportunities.

Japan Ureteral Stents Market

Japan contributes approximately 7% to the global Ureteral Stents Market share. A rapidly aging population drives sustained demand for urological procedures. High healthcare standards support the use of advanced stent materials. Technological innovation is strongly integrated into clinical practice. Hospitals emphasize patient comfort and long-term safety. Minimally invasive surgery adoption is high. Strong clinician expertise enhances procedural success rates. Regulatory compliance ensures product quality. Research-driven healthcare supports innovation. Japan remains a technologically advanced and stable market.

China Ureteral Stents Market

China accounts for approximately 10% of the global Ureteral Stents Market share and represents a high-growth region. A large patient population drives increasing procedure volumes. Expanding healthcare infrastructure improves access to urological care. Rising awareness supports early treatment adoption. Local manufacturing strengthens supply chain efficiency. Cost-effective products drive mass adoption. Government healthcare reforms support modernization. Urban hospitals lead advanced stent usage. Private healthcare expansion boosts demand. China plays a critical role in global market expansion.

Rest of the World

The Rest of the World holds approximately 10% of the Ureteral Stents Market share and shows gradual but steady growth. Improving healthcare infrastructure supports increased procedure volumes. Private healthcare facilities drive early adoption of advanced stents. Government investments enhance hospital capacity. Rising prevalence of kidney-related disorders boosts demand. Medical tourism supports adoption in select countries. Cost sensitivity influences product selection. Training initiatives improve clinical expertise. Urban centers lead usage trends. The region presents emerging Ureteral Stents Market Growth potential.

List of Top Ureteral Stents Companies

• Boston Scientific Corporation
• Cook
• Medtronic
• Richard Wolf GmbH
• Olympus Corporation
• Teleflex Incorporated
• Stryker
• KARL STORZ
• Dornier MedTech

Top Two Companies by Market Share

• Boston Scientific Corporation – 18%
• Cook – 15%

Investment Analysis and Opportunities

Investment activity in the Ureteral Stents Market continues to strengthen due to the rising prevalence of urological disorders and minimally invasive surgical procedures. Medical device manufacturers are investing in advanced stent materials to improve biocompatibility and patient comfort. Hospitals and specialty clinics are expanding urology departments, driving consistent device demand. Emerging markets present strong opportunities due to increasing healthcare infrastructure development. Innovation-focused investments target antimicrobial coatings and long-term indwelling stents. Strategic partnerships between device makers and healthcare providers enhance clinical adoption. Private equity interest remains steady in specialty medical devices. Regulatory approvals support commercialization of next-generation stents. Research funding accelerates product differentiation. Overall, the Ureteral Stents Market offers stable and procedure-driven investment opportunities.

New Product Development

New product development in the Ureteral Stents Market focuses on improving safety, durability, and ease of placement. Manufacturers are introducing stents with enhanced flexibility to reduce patient discomfort. Material innovation targets reduced encrustation and infection risks. Drug-coated and antimicrobial stents are gaining attention for long-term use cases. Design improvements enhance visibility during placement procedures. Customized stent sizing supports personalized patient care. Minimally invasive compatibility drives product design strategies. Advances in polymer science improve biocompatibility. Regulatory-aligned development shortens approval timelines. Continuous innovation strengthens competitive positioning within the Ureteral Stents Market.

Five Recent Developments (2023–2025)

• Introduction of antimicrobial-coated stents
• Expansion of long-term indwelling stent portfolios
• Manufacturing capacity upgrades
• Research into biodegradable stents
• Geographic expansion into emerging markets

Report Coverage of Ureteral Stents Market

The Ureteral Stents Market Report provides comprehensive coverage of industry structure, technological advancements, and competitive dynamics. It analyzes key market drivers, restraints, challenges, and growth opportunities. Detailed segmentation covers stent types, materials, applications, and end users. Regional analysis highlights adoption trends and market share distribution. The report profiles major manufacturers and their strategic initiatives. Investment trends and innovation pathways are evaluated in detail. Regulatory and clinical considerations are included. Market insights support strategic decision-making for stakeholders. The report addresses evolving healthcare demands. Overall, it delivers a complete and actionable overview of the Ureteral Stents Market.

Request for Customization   to gain extensive market insights.